Evidence map›Paper›PMID 28344911›Full record

ArticleCureus2017

Spontaneous Tumor Lysis Syndrome in Small Cell Lung Cancer.

Venkatkiran Kanchustambham, Swetha Saladi, Setu Patolia, David Stoeckel

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Tumor Lysis Syndrome in Lung Cancer Patients: A Review of the Literature.Asian Pacific journal of cancer prevention : APJCP · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Spontaneous tumor lysis syndrome in squamous cell carcinoma of the lung.Proceedings (Baylor University. Medical Center) · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Venkatkiran KanchustambhamPulmonary and Critical Care Medicine, Saint Louis University School of Medicine.
Swetha SaladiPulmonary and Critical Care Medicine, Saint Louis University School of Medicine.
Setu PatoliaPulmonary and Critical Care Medicine, Saint Louis University School of Medicine.
David StoeckelPulmonary and Critical Care Medicine, Saint Louis University School of Medicine.
Sanford Health · USPulmonary and Critical Care Associates · USUCLouvain Saint-Louis Brussels · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor lysis syndrome (TLS) is a life-threatening oncologic complication caused by the lysis of a vast number of malignant cells resulting in metabolic derangements and organ dysfunction. TLS can occur spontaneously before initiation of any therapies often referred to as spontaneous tumor lysis syndrome (STLS), or shortly after the induction of chemotherapy, radiotherapy, or cytolytic antibody therapy. TLS is vastly seen in patients with hematological malignancies with high rapid cell turnover rates such as Burkitt lymphoma, acute myelogenous leukemia, and acute lymphocytic leukemia, and is rarely observed in solid tumors. However, TLS can occur in solid tumors, and there are multiple reports in the literature on the occurrence of TLS in various solid tumors. In this article, we report a case of STLS in small cell lung cancer followed by a brief review of the occurrence of TLS and STLS in small cell lung cancer.

Indexed as

small cell lung cancerspontaneous tumor lysis syndrome (stls)tumour lysis syndrome (tls)

Identifiers

PMID28344911
PMCPMC5342890
OpenAlexW2587386599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.